wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38134302-5560F193-8D57-4BDD-ABB2-A8D5EBBD8536
Q38134302-5560F193-8D57-4BDD-ABB2-A8D5EBBD8536
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38134302-5560F193-8D57-4BDD-ABB2-A8D5EBBD8536
Inhibition of angiogenesis for the treatment of metastatic melanoma.
P2860
Q38134302-5560F193-8D57-4BDD-ABB2-A8D5EBBD8536
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38134302-5560F193-8D57-4BDD-ABB2-A8D5EBBD8536
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bfc16a8224b40ec2680bc51b97addc3f4c07e6d7
P2860
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma.